Literature DB >> 19471869

Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis.

Hongliang Wang1, Chengyu Jiang.   

Abstract

Influenza A virus H5N1 presents a major threat to human health. The entry of influenza virus into host cells is believed to be mediated by hemagglutinin (HA), a virus surface glycoprotein that can bind terminal sialic acid residues on host cell glycoproteins and glycolipids. In this study, we elucidated the pathways through which H5N1 enters human lung carcinoma cell line A549. We first proved that H5N1 can enter A549 cells via endocytosis, as lysosomotropic agents, such as bafilomycin A1 and chloroquine, can rescue H5N1-induced A549 cell death. By using specific inhibitors, and siRNAs that target the clathrin pathway, we further found that H5N1 could enter A549 cells via clathrin-mediated endocytosis, while inhibitors targeting caveolae-mediated endocytosis could not inhibit H5N1 cell entry. These findings expand our understanding of H5N1 pathogenesis and provide new information for anti-viral drug research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471869      PMCID: PMC7089391          DOI: 10.1007/s11427-009-0061-0

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  14 in total

1.  Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.

Authors:  Brooke Harmon; Benjamin R Schudel; Dianna Maar; Carol Kozina; Tetsuro Ikegami; Chien-Te Kent Tseng; Oscar A Negrete
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

2.  Baculovirus GP64-mediated entry into mammalian cells.

Authors:  Chikako Kataoka; Yuuki Kaname; Shuhei Taguwa; Takayuki Abe; Takasuke Fukuhara; Hideki Tani; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

3.  Neuraminidase of Influenza A Virus Binds Lysosome-Associated Membrane Proteins Directly and Induces Lysosome Rupture.

Authors:  Xiangwu Ju; Yiwu Yan; Qiang Liu; Ning Li; Miaomiao Sheng; Lifang Zhang; Xiao Li; Zhu Liang; Fengming Huang; Kangtai Liu; Yan Zhao; Yanxu Zhang; Zhen Zou; Jianchao Du; Ying Zhong; Huandi Zhou; Peng Yang; Huijun Lu; Mingyao Tian; Dangsheng Li; Jianming Zhang; Ningyi Jin; Chengyu Jiang
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

4.  Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury.

Authors:  Wei Wang; Penghui Yang; Ying Zhong; Zhongpeng Zhao; Li Xing; Yan Zhao; Zhen Zou; Yanli Zhang; Chenggang Li; Taisheng Li; Chen Wang; Zhong Wang; Xuezhong Yu; Bin Cao; Xiang Gao; Josef M Penninger; Xiliang Wang; Chengyu Jiang
Journal:  Cell Res       Date:  2013-02-19       Impact factor: 25.617

Review 5.  Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases.

Authors:  Md Abdul Alim Al-Bari
Journal:  Pharmacol Res Perspect       Date:  2017-01-23

Review 6.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

7.  Mutation S110L of H1N1 Influenza Virus Hemagglutinin: A Potent Determinant of Attenuation in the Mouse Model.

Authors:  Amelia Nieto; Jasmina Vasilijevic; Nuno Brito Santos; Noelia Zamarreño; Pablo López; Maria Joao Amorim; Ana Falcon
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

8.  Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model.

Authors:  Yiwu Yan; Zhen Zou; Yang Sun; Xiao Li; Kai-Feng Xu; Yuquan Wei; Ningyi Jin; Chengyu Jiang
Journal:  Cell Res       Date:  2012-12-04       Impact factor: 25.617

9.  A predictive signature gene set for discriminating active from latent tuberculosis in Warao Amerindian children.

Authors:  Lilly M Verhagen; Aldert Zomer; Mailis Maes; Julian A Villalba; Berenice Del Nogal; Marc Eleveld; Sacha Aft van Hijum; Jacobus H de Waard; Peter Wm Hermans
Journal:  BMC Genomics       Date:  2013-02-01       Impact factor: 3.969

10.  Entry properties and entry inhibitors of a human H7N9 influenza virus.

Authors:  Youhui Si; Jianguo Li; Yuqiang Niu; Xiuying Liu; Lili Ren; Li Guo; Min Cheng; Hongli Zhou; Jianwei Wang; Qi Jin; Wei Yang
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.